Pan European Prospective Observational Study of Fremanezumab effectiveness in patients with chronic or episodic migraine in the Real-World: PEARL study

07/05/2020
05/06/2026
EU PAS number:
EUPAS35111
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

PEARL Study Protocol a Real-World Study of Fremanezumab Effectiveness in Patients with Chronic or Episodic Migraine.pdf

English (1.09 MB - PDF) View document
Study results
Study report
Other information
Study, other information
https://www.tandfonline.com/doi/epdf/10.2217/pmt-2021-0015?needAccess=true
Publications
Study publications
https://journals.sagepub.com/doi/epub/10.1177/03331024231214987